Rhonda Patrick· PhD
But if you look at the opposite end of the spectrum, if you look at the difference between the middle 10% and the top 10% in terms of health expectancy and life expectancy, it's basically nil.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
But if you look at the opposite end of the spectrum, if you look at the difference between the middle 10% and the top 10% in terms of health expectancy and life expectancy, it's basically nil.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.